JournalsHub
.online
Find My Journal
PR

Petra Rietschel

Regeneron (United States) US

85
Publications
3,476
Citations
17
H-Index
23
i10-Index
3.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Phase II study of extended-dose temozolomide in patients with melanoma.

P. Rietschel, J. Wolchok, S. Krown, S. Gerst, A. Jungbluth - Journal of Clinical Oncology, 2008
Cited by 73 Semantic Scholar

Phase II trial of extended-dosing temozolomide in patients with melanoma

P. Rietschel, S. Ejadi, J. Wolchok, S. Krown, S. Gerst - Unknown Venue, 2006
Cited by 0 Semantic Scholar

Immunotherapy of melanoma.

P. Rietschel, P. Chapman - Hematology/Oncology Clinics of North America, 2006
Cited by 10 Semantic Scholar

Variates of survival in metastatic uveal melanoma. OA

P. Rietschel, K. Panageas, C. Hanlon, Ami Patel, D. Abramson - Journal of Clinical Oncology, 2005
Cited by 291 Semantic Scholar

Variates of survival for stage IV uveal melanoma

P. Rietschel, K. Panageas, C. Hanlon, Ami Patel, P. Chapman - Unknown Venue, 2005
Cited by 1 Semantic Scholar

Research Topics

Lung Cancer Treatments and Mutations (49) Cancer Immunotherapy and Biomarkers (44) Colorectal Cancer Treatments and Studies (15) Lung Cancer Research Studies (14) Cancer Genomics and Diagnostics (11)

Affiliations

Brigham and Women's Hospital
US 2001 - 2001
Albert Einstein College of Medicine
US 2013 - 2012
Memorial Sloan Kettering Cancer Center
US 2008 - 2005
Harvard University
US 2001 - 2000
Bayer (United States)
US 2014 - 2013

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now